Skip to main content
Erschienen in: Rheumatology International 1/2012

01.01.2012 | Original Article

Early endoscopy in systemic sclerosis without gastrointestinal symptoms

verfasst von: Rene Thonhofer, Cornelia Siegel, Markus Trummer, Winfried Graninger

Erschienen in: Rheumatology International | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Investigation into the upper GI-tract of patients suffering from systemic sclerosis [SSc] and mixed connective tissue disease [MCTD] without symptoms of GI-tract involvement early in the course of the disease to diagnose inflammatory and motility disorders. We retrospectively analysed patients with SSc and MCTD who underwent oesophago-gastro-duodenoscopy [OGD] within a year of the first diagnosis. Patients with a Rodnan skin score above 5, proton pump inhibitors and treatment regimes potentially harmful to the mucosa of the upper GI-tract were excluded. Mucosal damage of the oesophagus was classified according to the Los Angeles Classification. Oesophageal dysmotility was assessed during OGD and confirmed by video cineradiography. A total of thirteen patients with SSc and six with MCTD fulfilled the inclusion criteria. OGD revealed reflux-oesophagitis in 77%, dysmotility of the distal oesophagus in 85%, gastritis in 92% [31% erosive gastritis] and Helicobacter pylori positivity in 38% of our patients suffering from SSc. Patients with MCTD showed features of reflux-oesophagitis, dysmotility of the distal oesophagus, gastritis and dysmotility of the stomach in 0.6%. In all thirteen patients with SSc, significant pathology of the upper GI-tract was found. The results of this study might indicate that OGD should be performed early in patients diagnosed with SSc, even if they do not report typical symptoms. An early diagnose of GI involvement might be followed by an effective therapy and therefore subsequently may improve the prognosis.
Literatur
1.
Zurück zum Zitat Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H (2006) Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 24:1593–1601PubMedCrossRef Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H (2006) Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 24:1593–1601PubMedCrossRef
2.
Zurück zum Zitat Weihrauch TR, Korting GW, Ewe K, Vogt G (1978) Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr 56:963–968PubMedCrossRef Weihrauch TR, Korting GW, Ewe K, Vogt G (1978) Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr 56:963–968PubMedCrossRef
3.
Zurück zum Zitat Weston S, Thumshirn M, Wiste J, Camilleri M (1998) Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 93:1085–1089PubMedCrossRef Weston S, Thumshirn M, Wiste J, Camilleri M (1998) Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 93:1085–1089PubMedCrossRef
4.
Zurück zum Zitat Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA (2006) Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 36:173–181PubMedCrossRef Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA (2006) Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 36:173–181PubMedCrossRef
5.
Zurück zum Zitat Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876PubMed Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876PubMed
6.
Zurück zum Zitat Yamamoto M, Takahashi H, Akaike J, Suzuki C, Naishiro Y, Yamamoto H et al (2008) Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol 37:315–316PubMedCrossRef Yamamoto M, Takahashi H, Akaike J, Suzuki C, Naishiro Y, Yamamoto H et al (2008) Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol 37:315–316PubMedCrossRef
7.
Zurück zum Zitat Marie I, Levesque H, Ducrotté P, Denis P, Hellot MF, Benichou J et al (2001) Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 96:77–83PubMedCrossRef Marie I, Levesque H, Ducrotté P, Denis P, Hellot MF, Benichou J et al (2001) Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 96:77–83PubMedCrossRef
8.
Zurück zum Zitat Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K et al (2007) Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 34:2050–2055PubMed Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K et al (2007) Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 34:2050–2055PubMed
9.
Zurück zum Zitat Szamosi S, Szekanecz Z, Szucs G (2006) Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int 26:1120–1124PubMedCrossRef Szamosi S, Szekanecz Z, Szucs G (2006) Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int 26:1120–1124PubMedCrossRef
10.
Zurück zum Zitat Tsianos EB, Drosos AA, Chiras CD, Moutsopoulos HM, Kitridou RC (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27PubMedCrossRef Tsianos EB, Drosos AA, Chiras CD, Moutsopoulos HM, Kitridou RC (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27PubMedCrossRef
11.
Zurück zum Zitat Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107PubMedCrossRef Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107PubMedCrossRef
12.
Zurück zum Zitat Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef
13.
Zurück zum Zitat Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39:2209–2215PubMedCrossRef Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39:2209–2215PubMedCrossRef
14.
Zurück zum Zitat Treacy WL, Baggenstoss AH, Slocumb CH, Code CF (1963) Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 59:351–356PubMed Treacy WL, Baggenstoss AH, Slocumb CH, Code CF (1963) Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 59:351–356PubMed
15.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
16.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (2001) Criteria fort he Classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria fort he Classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
17.
Zurück zum Zitat von Mühlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323–358CrossRef von Mühlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323–358CrossRef
18.
Zurück zum Zitat Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed
19.
Zurück zum Zitat Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159PubMedCrossRef Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159PubMedCrossRef
20.
Zurück zum Zitat Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271PubMedCrossRef Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271PubMedCrossRef
21.
Zurück zum Zitat Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D’Angelo WA et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88PubMed Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D’Angelo WA et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88PubMed
22.
Zurück zum Zitat Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed
23.
Zurück zum Zitat Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP et al (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111:85–92PubMedCrossRef Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP et al (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111:85–92PubMedCrossRef
24.
Zurück zum Zitat Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Christoforidis P, Kourtessas D et al (2002) Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. Eur J Gastroenterol Hepatol 14:1237–1243PubMedCrossRef Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Christoforidis P, Kourtessas D et al (2002) Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. Eur J Gastroenterol Hepatol 14:1237–1243PubMedCrossRef
25.
Zurück zum Zitat Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto M, Gambari P et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto M, Gambari P et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed
26.
Zurück zum Zitat Franck-Larsson K, Hedenström H, Dahl R, Rönnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32:348–355PubMedCrossRef Franck-Larsson K, Hedenström H, Dahl R, Rönnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32:348–355PubMedCrossRef
27.
Zurück zum Zitat Hendel L, Hage E, Hendel J, Stentoft P (1992) Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 6:565–577PubMedCrossRef Hendel L, Hage E, Hendel J, Stentoft P (1992) Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 6:565–577PubMedCrossRef
Metadaten
Titel
Early endoscopy in systemic sclerosis without gastrointestinal symptoms
verfasst von
Rene Thonhofer
Cornelia Siegel
Markus Trummer
Winfried Graninger
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 1/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1595-y

Weitere Artikel der Ausgabe 1/2012

Rheumatology International 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.